Chengdu Bright Eye Hospital Co. Ltd. Market Cap ($772.86 Million)
Market Cap & Net Worth: Chengdu Bright Eye Hospital Co. Ltd. (301239)
Chengdu Bright Eye Hospital Co. Ltd. market cap. Chengdu Bright Eye Hospital Co. Ltd. (SHE:301239) has a market capitalization of $772.86 Million (CN¥5.28 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #9760 globally and #2475 in its home market, demonstrating a -3.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chengdu Bright Eye Hospital Co. Ltd.'s stock price CN¥35.30 by its total outstanding shares 149619048 (149.62 Million). Also see how efficiently does Chengdu Bright Eye Hospital Co. Ltd. generate cash for how efficiently the company converts equity into cash flow.
Chengdu Bright Eye Hospital Co. Ltd. Market Cap History (2022–2026)
Chengdu Bright Eye Hospital Co. Ltd. market cap history from 2022 to 2026. Data shows change from $1.53 Billion to $772.86 Million (-8.58% CAGR). Check 301239 live share price for real-time trading data and today's change.
Chengdu Bright Eye Hospital Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chengdu Bright Eye Hospital Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 301239 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.26x
Chengdu Bright Eye Hospital Co. Ltd.'s market cap is 0.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.53 Billion | $1.73 Billion | $20.57 Million | 0.89x | 74.27x |
| 2023 | $1.86 Billion | $2.72 Billion | $267.91 Million | 0.69x | 6.95x |
| 2024 | $1.03 Billion | $2.68 Billion | -$101.86 Million | 0.38x | N/A |
| 2025 | $720.09 Million | $2.80 Billion | -$60.92 Million | 0.26x | N/A |
Competitor Companies of 301239 by Market Capitalization
Companies near Chengdu Bright Eye Hospital Co. Ltd. in the global market cap rankings as of November 5, 2026. Also see Chengdu Bright Eye Hospital Co. Ltd. asset portfolio for a full breakdown of the balance sheet.
Key companies related to Chengdu Bright Eye Hospital Co. Ltd. by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #905 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #994 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1215 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $510.70 |
| #905 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €51.38 |
| #994 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1215 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $292.25 |
Market Capitalization of Chengdu Bright Eye Hospital Co. Ltd. (2022–2026)
Market capitalization of Chengdu Bright Eye Hospital Co. Ltd. from 2022 to today. Between 2022 and today, Chengdu Bright Eye Hospital Co. Ltd.'s market cap moved from $1.53 Billion to $ 772.86 Million, with a yearly change of -8.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥772.86 Million | +7.33% |
| 2025 | CN¥720.09 Million | -29.87% |
| 2024 | CN¥1.03 Billion | -44.87% |
| 2023 | CN¥1.86 Billion | +21.93% |
| 2022 | CN¥1.53 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Chengdu Bright Eye Hospital Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $772.86 Million USD |
| MoneyControl | $772.86 Million USD |
| MarketWatch | $772.86 Million USD |
| marketcap.company | $772.86 Million USD |
| Reuters | $772.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chengdu Bright Eye Hospital Co. Ltd.
Bright Eye Hospital Group Co., Ltd., together with its subsidiaries, operates ophthalmic medical institutions in China. The company offers ophthalmic diagnostic and treatment services, including refractive surgery, medical optometry and glasses fitting, cataract surgery, glaucoma treatment, strabismus and amblyopia, pediatric ophthalmology, fundus diseases treatment, oculoplastic surgery, lacrima… Read more